This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Anacor Pharmaceuticals, Inc., Glaxo Group Limited, Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Research Triangle Park, NC (US) (2012)
- Madrid, ES (2012)
- Tres Cantos, ES (2020 - 2022)
Company Filing History:
2 out of 70 
2 out of 1,170 
2 out of 95 
Years Active: 2012-2022
Title: The Innovative Journey of Carlos Alemparte-Gallardo
Introduction: Carlos Alemparte-Gallardo, a notable inventor based in Tres Cantos, Spain, has made significant contributions to the field of pharmaceutical compounds. With a total of five patents to his name, Alemparte-Gallardo's innovative work focuses on treatments for serious health conditions, showcasing his dedication to advancing medical science.
Latest Patents: Alemparte-Gallardo's latest patents include the development of 4-substituted benzoxaborole compounds and their therapeutic uses. These substituted benzoxaboroles are designed to combat mycobacterial infections and have potential applications in therapies targeting tuberculosis. His other recent invention, tetrazole compounds, also addresses the treatment of mycobacterial infections, providing further solutions in the ongoing battle against diseases such as tuberculosis. These compounds are not only innovative but also offer promising pathways for future medical therapies.
Career Highlights: Throughout his career, Alemparte-Gallardo has worked with esteemed organizations including Glaxo Group Limited and GlaxoSmithKline Intellectual Property (No. 2) Limited. His work within these companies has allowed him to explore and develop critical pharmaceutical innovations, contributing to the greater body of knowledge in medicinal chemistry and therapeutics.
Collaborations: Collaboration has played a key role in Alemparte-Gallardo's successes. He has partnered with fellow professionals such as David Barros-Aguirre and Monica Cacho-Izquierdo, pooling their expertise to drive research and development in their respective fields. These collaborations demonstrate the importance of teamwork in fostering innovation and creating impactful solutions.
Conclusion: Carlos Alemparte-Gallardo's inventive spirit and commitment to research have established him as a prominent figure in the realm of pharmaceuticals. His patents reflect his ongoing efforts to address critical health challenges, underlining the importance of innovation in improving patient outcomes. As he continues to explore new frontiers in medicinal chemistry, the medical community eagerly anticipates the impact of his future contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile